These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

464 related articles for article (PubMed ID: 9377834)

  • 21. Critical appraisal of antimicrobials for prevention of infections in immunocompromised hosts.
    Hathorn JW
    Hematol Oncol Clin North Am; 1993 Oct; 7(5):1051-99. PubMed ID: 8226565
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Management of mycoses in surgical patients -- review of the literature.
    Holzheimer RG; Dralle H
    Eur J Med Res; 2002 May; 7(5):200-26. PubMed ID: 12069912
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Current trends in the epidemiology of bloodstream infections in patients with hematological malignancies and solid neoplasms].
    Dan M; Mereuţă A; Pânzaru C; Miron I; Turtureanu-Hanganu E; Buiuc D
    Rev Med Chir Soc Med Nat Iasi; 2006; 110(1):57-61. PubMed ID: 19292079
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacokinetics and effects on bowel and throat microflora of oral levofloxacin as antibacterial prophylaxis in neutropenic patients with haematological malignancies.
    Timmers GJ; Dijstelbloem Y; Simoons-Smit AM; van Winkelhoff AJ; Touw DJ; Vandenbroucke-Grauls CM; Huijgens PC
    Bone Marrow Transplant; 2004 Apr; 33(8):847-53. PubMed ID: 14755314
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevention of bacterial and fungal infections in granulocytopenic patients.
    Verhoef J; Rozenberg-Arska M; Dekker AW
    Eur J Cancer Clin Oncol; 1989 Sep; 25(9):1345-50. PubMed ID: 2680513
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevention and treatment of invasive fungal diseases in neutropenic patients.
    Almyroudis NG; Segal BH
    Curr Opin Infect Dis; 2009 Aug; 22(4):385-93. PubMed ID: 19506476
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gram-negative organisms predominate in Hickman line-related infections in non-neutropenic patients with hematological malignancies.
    Chee L; Brown M; Sasadeusz J; MacGregor L; Grigg AP
    J Infect; 2008 Apr; 56(4):227-33. PubMed ID: 18342947
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antimicrobial prophylaxis in febrile neutropenia.
    Yoshida M; Ohno R
    Clin Infect Dis; 2004 Jul; 39 Suppl 1():S65-7. PubMed ID: 15250025
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Treatment and prevention of infections in cancer patients with neutropenia].
    Sinkó J
    Magy Onkol; 2011 Sep; 55(3):155-63. PubMed ID: 21918740
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Management of infections in immunocompromised cancer patients.
    Bajetta E; Gasparini G; Monfardini S; Volonterio A; Buzzoni R; Shinde S
    Haematologica; 1984; 69(5):576-97. PubMed ID: 6437936
    [No Abstract]   [Full Text] [Related]  

  • 31. Clinical guidelines for the management of neutropenic patients with unexplained fever in Japan: validation by the Japan Febrile Neutropenia Study Group.
    Tamura K
    Int J Antimicrob Agents; 2005 Dec; 26 Suppl 2():S123-7; discussion S133-40. PubMed ID: 16249072
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prophylactic action of oral fluconazole against fungal infection in neutropenic patients. A meta-analysis of 16 randomized, controlled trials.
    Kanda Y; Yamamoto R; Chizuka A; Hamaki T; Suguro M; Arai C; Matsuyama T; Takezako N; Miwa A; Kern W; Kami M; Akiyama H; Hirai H; Togawa A
    Cancer; 2000 Oct; 89(7):1611-25. PubMed ID: 11013378
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment of fungal and other opportunistic infections in immunocompromised patients.
    Wade JC
    Leukemia; 1997 May; 11 Suppl 4():S38-9. PubMed ID: 9179282
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Failure of fluconazole prophylaxis to reduce mortality or the requirement of systemic amphotericin B therapy during treatment for refractory acute myeloid leukemia: results of a prospective randomized phase III study. German AML Cooperative Group.
    Kern W; Behre G; Rudolf T; Kerkhoff A; Grote-Metke A; Eimermacher H; Kubica U; Wörmann B; Büchner T; Hiddemann W
    Cancer; 1998 Jul; 83(2):291-301. PubMed ID: 9669812
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Nosocomial infections in neutropenic patients].
    Cordonnier C
    Rev Prat; 1989 May; 39(16):1403-8. PubMed ID: 2740792
    [TBL] [Abstract][Full Text] [Related]  

  • 36. How to improve the design of trials of antifungal prophylaxis among neutropenic adults with acute leukemia.
    Menichetti F
    Clin Infect Dis; 2004 Oct; 39 Suppl 4():S181-4. PubMed ID: 15546115
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Bacterial septicemia in neutropenia patients].
    Vernant JP; Thibault M; Cordonnier C; Feghali W; Brun B; Dreyfus B; Duval J; Rochant H
    Ann Med Interne (Paris); 1983; 134(7):629-35. PubMed ID: 6666900
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Fungal infections in granulocytopenic and immunocompromised patients].
    Schwenke H
    Z Gesamte Inn Med; 1992 Sep; 47(9):422-37. PubMed ID: 1441671
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Selective decontamination of the digestive tract for the prevention of infection in patients with neutropenia].
    Bláha M; Vacková M; Vanásek J; Splino M; Jebavý L; Malý J; Pecka M
    Vnitr Lek; 1986 Aug; 32(8):790-6. PubMed ID: 3765417
    [No Abstract]   [Full Text] [Related]  

  • 40. Strategies for managing systemic fungal infection and the place of itraconazole.
    Potter M
    J Antimicrob Chemother; 2005 Sep; 56 Suppl 1():i49-i54. PubMed ID: 16120634
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.